Chemoinformaics analysis of 1-6-di-o-galloyl-beta-d-glucose
| Molecular Weight | 484.366 | nRot | 5 |
| Heavy Atom Molecular Weight | 464.206 | nRig | 20 |
| Exact Molecular Weight | 484.085 | nRing | 3 |
| Solubility: LogS | -2.112 | nHRing | 1 |
| Solubility: LogP | 0.121 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 54 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 34 | No. of Aromatic Carbocycles | 2 |
| nHetero | 14 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 20 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 14 | No. of Arom Bond | 12 |
| nHA | 14 | APOL | 57.9639 |
| nHD | 9 | BPOL | 27.0081 |
| QED | 0.178 |
| Synth | 4.005 |
| Natural Product Likeliness | 1.344 |
| NR-PPAR-gamma | 0.316 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.009 |
| Pgp-sub | 0.028 |
| HIA | 0.87 |
| CACO-2 | -6.734 |
| MDCK | 0.0000182 |
| BBB | 0.044 |
| PPB | 0.8977 |
| VDSS | 0.487 |
| FU | 0.1268 |
| CYP1A2-inh | 0.229 |
| CYP1A2-sub | 0.017 |
| CYP2c19-inh | 0.02 |
| CYP2c19-sub | 0.035 |
| CYP2c9-inh | 0.203 |
| CYP2c9-sub | 0.055 |
| CYP2d6-inh | 0.021 |
| CYP2d6-sub | 0.114 |
| CYP3a4-inh | 0.033 |
| CYP3a4-sub | 0.005 |
| CL | 7.866 |
| T12 | 0.967 |
| hERG | 0.354 |
| Ames | 0.137 |
| ROA | 0 |
| SkinSen | 0.953 |
| Carcinogencity | 0.022 |
| EI | 0.901 |
| Respiratory | 0.009 |
| NR-Aromatase | 0.183 |
| Antiviral | Yes |
| Prediction | 0.68652 |